GYNISUS

Intelligent Healthcare Insights and Predictions

Health Tech & Life Sciences
Non Active, Aug 2024 ceased to operate
Seed Tel Aviv-Yafo Founded 2017
LinkedIn
Total raised
$50K
Last: Seed 2023-03
Stage
Seed
Founded
2017
Headcount
31
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Gynisus uses artificial intelligence to improve the way people are diagnosed and treated. The company's SPAI platform provides intelligent insights and predictions for the healthcare space. Gynisus seeks to help hospitals and physicians focus on patients at higher risk for complications and disease as well as to enable better forecasting in the areas of resource utilization and cost management. Powered by SPAI, the Infectious Disease Intelligence Platform supports hospitals, home nursing facilities, and senior living centers to help slow the spread of COVID-19 by identifying people, prior to testing, who are likely to be infected with the virus, as well as the people who have come in contact with them. The solution has been implemented in medical centers in New York.

Funding history · 3 rounds · $50K total

2023-03
Seed Undisclosed
2022-07
Seed Undisclosed
2019-07
Undisclosed Round Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial Intelligence
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

early-detectionsoftware-applicationsnon-invasivewomen-healthwomengynecologyhospitalsartificial-intelligencedecision-supportdigital-healthcare